JP2003514549A - Ｇタンパク質共役受容体 - Google Patents

Ｇタンパク質共役受容体

Info

Publication number
JP2003514549A
JP2003514549A JP2001538968A JP2001538968A JP2003514549A JP 2003514549 A JP2003514549 A JP 2003514549A JP 2001538968 A JP2001538968 A JP 2001538968A JP 2001538968 A JP2001538968 A JP 2001538968A JP 2003514549 A JP2003514549 A JP 2003514549A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
mch
nucleic acid
expression vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001538968A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003514549A5 (enExample
Inventor
リウ，チンユン
マクドナルド，テレンス・ピー
ハワード，アンドリユー・デイー
央 岩浅
秀樹 佐野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Merck and Co Inc
Original Assignee
Banyu Phamaceutical Co Ltd
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd, Merck and Co Inc filed Critical Banyu Phamaceutical Co Ltd
Publication of JP2003514549A publication Critical patent/JP2003514549A/ja
Publication of JP2003514549A5 publication Critical patent/JP2003514549A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2001538968A 1999-11-16 2000-11-14 Ｇタンパク質共役受容体 Withdrawn JP2003514549A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16587199P 1999-11-16 1999-11-16
US60/165,871 1999-11-16
US18897700P 2000-03-13 2000-03-13
US60/188,977 2000-03-13
US19802900P 2000-04-18 2000-04-18
US60/198,029 2000-04-18
PCT/US2000/031240 WO2001036479A1 (en) 1999-11-16 2000-11-14 G-protein coupled receptor

Publications (2)

Publication Number Publication Date
JP2003514549A true JP2003514549A (ja) 2003-04-22
JP2003514549A5 JP2003514549A5 (enExample) 2007-12-27

Family

ID=27389191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001538968A Withdrawn JP2003514549A (ja) 1999-11-16 2000-11-14 Ｇタンパク質共役受容体

Country Status (5)

Country Link
US (1) US6593108B1 (enExample)
EP (1) EP1233981A4 (enExample)
JP (1) JP2003514549A (enExample)
CA (1) CA2392090A1 (enExample)
WO (1) WO2001036479A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002296277A (ja) * 2000-07-05 2002-10-09 Takeda Chem Ind Ltd Ｍｃｈ受容体アンタゴニスト・アゴニストのスクリーニング方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062797A2 (en) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company G protein-coupled receptors
DE60143525D1 (de) 2000-07-05 2011-01-05 Takeda Pharmaceutical Verfahren zum screenen von mhc-rezeptorantagonisten oder -agonisten
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US7208282B2 (en) * 2001-05-31 2007-04-24 Merck & Co., Inc. Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor
US7141391B2 (en) 2001-11-13 2006-11-28 Neurogen Corporation Monkey and canine melanin concentrating hormone receptors
PL376659A1 (pl) 2002-11-06 2006-01-09 Tularik Inc. Skondensowane związki heterocykliczne
KR100820095B1 (ko) 2006-12-14 2008-04-07 부경대학교 산학협력단 양식 넙치의 멜라닌 농축 호르몬 수용체

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214857D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5686597A (en) 1995-06-06 1997-11-11 Incyte Pharmaceuticals, Inc. Thrombin receptor homolog
EP0848060A3 (en) 1996-12-11 2000-02-02 Smithkline Beecham Corporation Novel human 11CB splice variant
EP1153932A1 (en) * 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2001007611A2 (en) 1999-07-26 2001-02-01 Genentech, Inc. Novel polynucleotides and method for the use thereof
WO2001007606A1 (en) 1999-07-27 2001-02-01 Smithkline Beecham Plc Axor21, a g-protein coupled receptor
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2001062797A2 (en) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company G protein-coupled receptors
JP2005229804A (ja) 2000-03-24 2005-09-02 Astellas Pharma Inc 新規なメラニンコンセントレーティングホルモン受容体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002296277A (ja) * 2000-07-05 2002-10-09 Takeda Chem Ind Ltd Ｍｃｈ受容体アンタゴニスト・アゴニストのスクリーニング方法

Also Published As

Publication number Publication date
WO2001036479A1 (en) 2001-05-25
EP1233981A4 (en) 2003-02-12
EP1233981A1 (en) 2002-08-28
US6593108B1 (en) 2003-07-15
CA2392090A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
CA2220036A1 (en) Human neuropeptide receptor
JP3064015B2 (ja) プロスタグランジンレセプターｄｐ
US5955308A (en) cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor
US6599718B1 (en) Growth hormone secretagogue related receptors and nucleic acids
US6017533A (en) Peptides having specific affinity to pituitary adenylate cyclase activating polypeptide type 1 receptors
JPH10295376A (ja) ヒトｇｐｒ１４レセプターのクローニング
EP0790305A1 (en) Mutant human growth hormones and their uses
JP2003514549A (ja) Ｇタンパク質共役受容体
JP2000083669A (ja) Ｃｘｃｒ４ケモカイン受容体のヒトスプライス変異体ｃｘｃｒ４ｂ
JP2003530821A (ja) メラニン凝集ホルモン受容体
JP5117853B2 (ja) 甲状腺刺激ホルモンレセプター試料、該甲状腺刺激ホルモンレセプターの結合部位、抗体及び該結合部位とのホルモンの相互作用、およびそれらの使用
US7074594B2 (en) Guanosine triphosphate (GTP) binding protein-coupled receptor proteins
US5874252A (en) Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor
US6274333B1 (en) Type-2 neurotensin receptor (NT-R2)
AU5545999A (en) Endogenous constitutively activated g protein-coupled orphan receptors
US6162899A (en) Human HNEAA81 receptor
US6277960B1 (en) cDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor
US7208282B2 (en) Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor
JP2004506419A (ja) イヌメラニン凝集ホルモン受容体
EP1012281B1 (en) Human leukocyte calcium activated potassium channel polypeptide
US20040248129A1 (en) Rhesus monkey, dog and feeret melanin-concentrating hormone type 1 receptor
JP2005508632A (ja) メラニン凝集ホルモン受容体アンタゴニスト結合タンパク質
US20070178462A1 (en) Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
JP2003507392A (ja) 高血圧症を含む、ヒトの疾患を診断及び治療する方法
EP1358196A2 (en) Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071101

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071101

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20091130